Evidence map›Paper›PMID 37356171›Full record

ArticleThrombosis research2023

Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation.

Jonathan Avery, Danielle Guffey, Shengling Ma, Ryan Basom, Stephanie J Lee, David Garcia, Cristhiam M Rojas Hernandez, Ang Li, Kylee L Martens

Open access · greenAbstract read
In one paragraph

Article in Thrombosis research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jonathan AveryUniversity of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195, United States.
Danielle GuffeyInstitute for Clinical and Translational Research, Baylor College of Medicine, One Baylor Plaza, BCM 451, Houston, TX 77030, United States.
Shengling MaSection of Hematology-Oncology, Baylor College of Medicine, One Baylor Plaza, MS:187, Houston, TX 77030, United States.
Ryan BasomClinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., P.0. Box 19024, Seattle, WA 98109, United States.
Stephanie J LeeClinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., P.0. Box 19024, Seattle, WA 98109, United States.
David GarciaDivision of Hematology, University of Washington, Seattle, WA, 1705 NE Pacific St, Seattle, WA 98195, United States.
Cristhiam M Rojas HernandezSection of Benign Hematology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States.
Ang LiSection of Hematology-Oncology, Baylor College of Medicine, One Baylor Plaza, MS:187, Houston, TX 77030, United States. Electronic address: ang.li2@bcm.edu.
Kylee L MartensDivision of Hematology and Medical Oncology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, United States.
Baylor College of Medicine · USFred Hutch Cancer Center · USUniversity of Washington · USOregon Health & Science University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
AIM-AHEAD Coordinating Center - All Four CoresOT2OD032581 · OD · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI Paul Avillach, Bettina M. Beech · 2021 to 2026
$168.7M
VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Evan Newell · 1985 to 2026
$128.4M
Epidemiology and Biomarkers in Transplant Associated Thrombotic Microangiopathy (TA-TMA): A Prospective Validation Cohort StudyK23HL159271 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Ang Li · 2022 to 2026
$835k
NCI NIH HHS P01 CA018029NCI NIH HHS P30 CA015704NHLBI NIH HHS K23 HL159271NIH HHS OT2 OD032581
6 · The paper itself

Abstract

introductionPatients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) require indwelling central venous catheters. The comparative incidence, risk, and outcome of isolated catheter-related deep venous thrombosis (CR-DVT) versus pulmonary embolism/lower-extremity DVT (PE/LE-DVT) remains unclear. MATERIALS AND

methodsWe conducted a retrospective cohort study for patients undergoing allo-HSCT from 2006 to 2019. CR-DVT and PE/LE-DVT outcomes were screened using ICD codes and radiology reports and confirmed by medical record reviews. Cox regression models were used to assess the association between thrombotic outcomes and pertinent baseline and time-varying covariates. The impact of thrombotic events within 1-year post-transplant (time-varying) on overall mortality was also assessed.

resultsAmong 2879 patients, the cumulative incidence of isolated CR-DVT and PE/LE-DVT at 12 months was 4.2 % and 4.8 %, respectively. The strongest time-varying predictor for onset of CR-DVT and PE/LE-DVT was hospitalization inpatient status (HR 3.71 [95 % CI 2.16-6.37] and 3.99 [95 % CI 2.00-7.99], respectively). Other overlapping variables included lymphoma diagnosis and BMI > 35 kg/m

conclusionsWe observed a high incidence of both CR-DVT and PE/LE-DVT with overlapping and unique risk factors. CR-DVT was also associated with increased mortality similar to PE/LE-DVT. Standardized strategies targeting high-risk hospitalization periods may help mitigate the development of thrombotic outcomes post-transplant.

Indexed as

Central Venous CathetersGraft vs Host DiseaseHematopoietic Stem Cell TransplantationPulmonary EmbolismVenous ThrombosisHumansRetrospective StudiesRisk FactorsCentral venous catheterCentral venous catheter adverse effectsNatural language processingStem cell transplantationThrombosis

Identifiers

PMID37356171
PMCPMC10527315
OpenAlexW4380883046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.